Breast Clinical Trials
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
BreastCancerMetastatic+2 more
University of Southern California65 enrolled3 locationsNCT04333706
Recruiting
Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
Breast CancerBreastPathology
Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 enrolled1 locationNCT07252986
Recruiting
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Breast CancerBreast
Wake Forest University Health Sciences102 enrolled2 locationsNCT04174742